tadalafil accord 5 mg filmom obalené tablety
accord healthcare polska sp. z o.o., poľsko - tadalafil - 83 - vasodilatantia
tadalafil accord 2,5 mg filmom obalené tablety
accord healthcare polska sp. z o.o., poľsko - tadalafil - 83 - vasodilatantia
silodosin accord 8 mg tvrdé kapsuly
accord healthcare polska sp. z o.o., poľsko - silodozín - 77 - sympatholytica
tenofovir disoproxil accordpharma 245 mg filmom obalené tablety
accord healthcare polska sp. z o.o., poľsko - tenofovir dizoproxil - 42 - chemotherapeutica (vratane tuberkulostatik)
exemestane accord 25 mg filmom obalené tablety
accord healthcare limited - exemestán - 44 - cytostatica
vildagliptin accord 50 mg tablety
accord healthcare polska sp. z o.o., poľsko - vildagliptín - 18 - antidiabetica (vrÁtane inzulÍnu)
cyklofosfamid accord 1 000 mg prášok na injekčný/infúzny roztok
accord healthcare polska sp. z o.o., poľsko - cyklofosfamid - 44 - cytostatica
cyklofosfamid accord 500 mg prášok na injekčný/infúzny roztok
accord healthcare polska sp. z o.o., poľsko - cyklofosfamid - 44 - cytostatica
cyklofosfamid accord 2000 mg prášok na injekčný /infúzny roztok
accord healthcare polska sp. z o.o., poľsko - cyklofosfamid - 44 - cytostatica
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastické činidlá - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.